Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)

• Company Description    Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Number of Employees: 55

• Price / Volume Information    Yesterday's Closing Price: $4.46 Daily Weekly Monthly 20 Day Moving Average: 31,410 shares Shares Outstanding: 7.91 (millions) Market Capitalization: $35.26 (millions) Beta: 0.53 52 Week High: $13.50 52 Week Low: $4.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -30.09% -23.71% 12 Week -31.49% -27.87% Year To Date -42.45% -32.92%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1633 BROADWAY SUITE 22C - NEW YORK,NY 10019 USA ph: 212-489-2100 fax: 212-489-2102 investorrelations@delcath.com http://www.delcath.com

• General Corporate Information    Officers Gerard Michel - Chief Executive Officer and Director Roger G. Stoll - Chairman of the Board Elizabeth Czerepak - Director Steven Salamon - Director John R. Sylvester - Director Peer Information Delcath Systems, Inc. (ABMD) Delcath Systems, Inc. (DMDS) Delcath Systems, Inc. (CPWY.) Delcath Systems, Inc. (EQUR) Delcath Systems, Inc. (ECIA) Delcath Systems, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 24661P807 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/09/22 Share - Related Items Shares Outstanding: 7.91 Most Recent Split Date: 12.00 (0.00:1) Beta: 0.53 Market Capitalization: $35.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.88 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.15 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.75 Price/Cash Flow: - Price / Sales: 9.95 EPS Growth vs. Year Ago Period: 3.85% vs. Previous Quarter: -44.93% Sales Growth vs. Year Ago Period: -2.58% vs. Previous Quarter: -82.07% ROE 03/31/22 - -246.07 12/31/21 - -174.36 09/30/21 - -158.51 ROA 03/31/22 - -90.52 12/31/21 - -82.22 09/30/21 - -86.56 Current Ratio 03/31/22 - 2.93 12/31/21 - 5.23 09/30/21 - 6.03 Quick Ratio 03/31/22 - 2.70 12/31/21 - 4.99 09/30/21 - 5.80 Operating Margin 03/31/22 - -764.84 12/31/21 - -721.72 09/30/21 - -1,498.41 Net Margin 03/31/22 - -764.84 12/31/21 - -721.72 09/30/21 - -1,498.41 Pre-Tax Margin 03/31/22 - -764.81 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 0.66 12/31/21 - 1.62 09/30/21 - 1.59 Inventory Turnover 03/31/22 - 0.40 12/31/21 - 0.54 09/30/21 - 0.68 Debt-to-Equity 03/31/22 - 2.55 12/31/21 - 1.26 09/30/21 - 1.32 Debt-to-Capital 03/31/22 - 71.81 12/31/21 - 55.67 09/30/21 - 56.83

Powered by Zacks Investment Research ©